Express Scripts has announced a plan to cut patient ... assurance programme” that the pharmacy benefit manager (PBM) is launching for members of participating non-government funded pharmacy ...

Express Scripts also wants Khan to be recused from any actions that involve the company. The FTC's long-awaited report published in July was a difficult read for the PBM industry, concluding that ...

This was days after Express Scripts started the legal volleying with a federal lawsuit against the FTC, which accused the agency of making false and misleading claims about the PBM industry in a ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

"This case involves an unlawful price-fixing agreement among several PBMs—orchestrated by the PBM rate aggregator ... which ...

GoodRx and pharmacy benefit managers CVS Caremark, Express Scripts, MedImpact and Navitus Health Solutions are facing class-action lawsuits accusing them of colluding to super press reimbursements to ...

The biggest pharmacy benefit managers are profiting by systematically underpaying independent drugstores, creating “pharmacy ...

Kentucky’s attorney general is suing the pharmacy benefit manager (PBM) Express Scripts over its role in “worsening” the state’s opioid crisis. In the complaint filed in state court ...

Drug coupon aggregator GoodRx and pharmacy benefit managers including CVS Caremark and Express Scripts have been hit with at least three class action lawsuits accusing them of working together to ...

The FTC believes that Caremark, Express Scripts, and OptumRx threatened to ... which includes its PBM unit, generated roughly 46% of its total revenue. Cigna's PBM contributed nearly 82% of ...

The FTC announced the lawsuit last month against CVS Caremark, Cigna’s Express Scripts and UnitedHealth ... “Event participants wore anti-PBM paraphernalia, including pins that vilified ...

In particular, the agency argued that the rebate practices of Caremark, Express Scripts, and OptumRx caused the list prices of insulin drugs to be artificially high and limited patients' access to ...